Skip To Main Content
Lindsay A on Muck Rack

Lindsay A

As seen in: Frontiers, PNAS

Get in touch with Lindsay

Contact Lindsay, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Monovalent SARS-COV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants | Proceedings of the National Academy of Sciences

|
By Lindsay A, Elika Bergelson, Melanie Soderstrom, Iris-Corinna Schwarz
| PNAS Verified
Monovalent SARS-COV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants Zhongfeng Ye https://orcid.org/0000-0003-0383-7247, Srinivasa Reddy Bonam https://orcid.org/0000-0002-2888-2418, Lindsay G. A. McKay https://orcid.org/0000-0003-0369-9067, +16 , Jessica A.
Open in Who Shared Issue with article?

A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta

|
By Paulo J. C, Acuitas Therapeutics, Lindsay A, Chien-Te K
| Frontiers
Introduction Current strategies for COVID-19 vaccine design utilize one or more SARS-CoV-2 Spike protein subunits to primarily activate the humoral arm of the adaptive immune response to produce neutralizing antibodies to the Spike receptor binding domain (RBD) (1, 2).
Open in Who Shared Issue with article?
See all 2 articles